Lanalidomide with Zn-DDC clinical trials

Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma

This study is looking into a drug called Zn-DDC (also known as Imuthiol) for multiple myeloma and other blood cancers. Researchers want to see how this drug, alone and with other common treatments (Lenalidomide, Pomalidomide), affects cancer cells in the lab. The goal is to find effective and affordable new treatment combinations.